ASH 2012: Dr. Shah- The Novel KSP Inhibitor ARRY-520 Is Active Both with and without Low-Dose Dexamethasone in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide: Results From a Phase 2 Study
Jatin Shah, MD University of Texas Houston, TX
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.